Barely Significant
← all excerpts

Treatment De-escalation in Relapsing-Remitting Multiple Sclerosis: An Observational Study.

CNS Drugs · 2025 · PMC11909097 · PMID 39953338

Europe PMCDOI
1
hedged sentence
0.6000
closest p · 12.0× alpha
0.6000
boldest claim

The sentences

did not reach statistical significancep = 0.6not close (p > 0.1)
In regards to recurrent events, the results did not reach statistical significance (259 events, HR 1.08 [0.82–1.40], p = 0.6).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.